Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CRTH2 antagonists(Prostaglandin D2 receptor 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC29H32N2O5 |
InChIKeyNNHVHOSSHPGFHJ-UHFFFAOYSA-N |
CAS Registry1263409-33-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | US | 01 Feb 2011 |